To assess the potential of pharmacologically activating autophagy/mitophagy through the AMPK pathway during LCWE-induced KD vasculitis, we treated WT mice with MN58b, a choline kinase α inhibitor, known to activate AMPK and to reduce ROS and mtDNA release (48). The gene discussed is CHKA; the disease is vasculitis.